The general outline of a pharma or biotech engineering project includes phases and tasks that typically span 2–3 years. The concept of phased engineering, procurement, and construction (EPC) is revisited in a paper co-authored by José Cardoso Menezes from BERG-iBB and colleagues and published in Pharmaceutical Engineering. The concept is further updated with risk-based considerations specifically regarding the commissioning, qualification, and validation (CQV) of general life-cycle principles for pharma and biotech projects.